334 related articles for article (PubMed ID: 15070680)
21. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Rothmeier AS; Liu E; Chakrabarty S; Disse J; Mueller BM; Østergaard H; Ruf W
Blood; 2018 Feb; 131(6):674-685. PubMed ID: 29246902
[TBL] [Abstract][Full Text] [Related]
22. Differential gene expression in activated monocyte-derived macrophages following binding of factor VIIa to tissue factor.
Muth H; Kreis I; Zimmermann R; Tillmanns H; Hölschermann H
Thromb Haemost; 2005 Nov; 94(5):1028-34. PubMed ID: 16363246
[TBL] [Abstract][Full Text] [Related]
23. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
[TBL] [Abstract][Full Text] [Related]
24. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
25. Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Zhu T; Mancini JA; Sapieha P; Yang C; Joyal JS; Honoré JC; Leduc M; Zaniolo K; Hardy P; Shao Z; Fan L; Hou X; Rivard GE; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R577-85. PubMed ID: 21160057
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
27. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling.
Mandal SK; Pendurthi UR; Rao LV
Blood; 2007 Jul; 110(1):161-70. PubMed ID: 17384202
[TBL] [Abstract][Full Text] [Related]
28. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
[TBL] [Abstract][Full Text] [Related]
29. Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
Featherby S; Madkhali Y; Maraveyas A; Ettelaie C
Thromb Haemost; 2019 Sep; 119(9):1419-1432. PubMed ID: 31266079
[TBL] [Abstract][Full Text] [Related]
30. Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae.
Awasthi V; Mandal SK; Papanna V; Rao LV; Pendurthi UR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1447-55. PubMed ID: 17413039
[TBL] [Abstract][Full Text] [Related]
31. Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.
Roy A; Ansari SA; Das K; Prasad R; Bhattacharya A; Mallik S; Mukherjee A; Sen P
J Biol Chem; 2017 Aug; 292(33):13688-13701. PubMed ID: 28522609
[TBL] [Abstract][Full Text] [Related]
32. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
33. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
34. Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study.
Petersen LC; Nørby PL; Branner S; Sørensen BB; Elm T; Stennicke HR; Persson E; Bjørn SE
Thromb Res; 2005; 116(1):75-85. PubMed ID: 15850611
[TBL] [Abstract][Full Text] [Related]
35. Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Koizume S; Jin MS; Miyagi E; Hirahara F; Nakamura Y; Piao JH; Asai A; Yoshida A; Tsuchiya E; Ruf W; Miyagi Y
Cancer Res; 2006 Oct; 66(19):9453-60. PubMed ID: 17018600
[TBL] [Abstract][Full Text] [Related]
36. Tissue factor as a novel target for treatment of breast cancer.
Cole M; Bromberg M
Oncologist; 2013; 18(1):14-8. PubMed ID: 23287882
[TBL] [Abstract][Full Text] [Related]
37. The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Carneiro-Lobo TC; Schaffner F; Disse J; Ostergaard H; Francischetti IM; Monteiro RQ; Ruf W
J Thromb Haemost; 2012 Sep; 10(9):1849-58. PubMed ID: 22823596
[TBL] [Abstract][Full Text] [Related]
38. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression.
Camerer E; Gjernes E; Wiiger M; Pringle S; Prydz H
J Biol Chem; 2000 Mar; 275(9):6580-5. PubMed ID: 10692465
[TBL] [Abstract][Full Text] [Related]
39. [Investigation of the mechanisms of coagulation factor VIIa-induced colon cancer SW620 cell proliferation and migration].
Shi WX; Zhou H; Li N; Huang HL; Zhou BC
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):485-9. PubMed ID: 19950693
[TBL] [Abstract][Full Text] [Related]
40. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain.
Sørensen BB; Freskgård PO; Nielsen LS; Rao LV; Ezban M; Petersen LC
J Biol Chem; 1999 Jul; 274(30):21349-54. PubMed ID: 10409695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]